Recent studies have indicated that circulating microRNAs (miRNAs) in serum and plasma are stable and can serve as biomarkers of many human diseases. Measurement of circulating miRNAs with sufficient sensitivity and precision, however, faces some special challenges, among which proper normalization is the most critical but often an underappreciated issue. The primary aim of this study was to identify endogenous reference genes that maintain consistent levels under various conditions to serve as an internal control for quantification of serum miRNAs. We developed a strategy combining Illumina’s sequencing by synthesis (SBS) technology, reverse transcription quantitative polymerase chain reaction (RT-qPCR) assay, literature screening and statistical analysis to screen and validate the most suitable reference genes. A combination of let-7d, let-7g and let-7i is selected as a reference for the normalization of serum miRNAs and it is statistically superior to the commonly used reference genes U6, RNU44, RNU48 and miR-16. This has important implications for proper experimental design and accurate data interpretation.
Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355. doi:10.1038/nature02871. PubMed: 15372042.
[3]
He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531. doi:10.1038/nrg1379. PubMed: 15211354.
[4]
Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675. doi:10.1111/j.1365-2141.2008.07077.x. PubMed: 18318758.
[5]
Chen X, Ba Y, Ma L, Cai X, Yin Y et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006. doi:10.1038/cr.2008.282. PubMed: 18766170.
[6]
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518. PubMed: 18663219.
[7]
Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA et al. (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15: 5473-5477. doi:10.1158/1078-0432.CCR-09-0736. PubMed: 19706812.
[8]
Hanke M, Hoefig K, Merz H, Feller AC, Kausch I et al. (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 28: 655-661. doi:10.1016/j.urolonc.2009.01.027. PubMed: 19375957.
[9]
Kosaka N, Izumi H, Sekine K, Ochiya T (2010) microRNA as a new immune-regulatory agent in breast milk. Silence. p. 1: 7.
[10]
Chen X, Gao C, Li H, Huang L, Sun Q et al. (2010) Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products. Cell Res 20: 1128-1137. doi:10.1038/cr.2010.80. PubMed: 20548333.
[11]
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-666. PubMed: 20159880.
[12]
Wang K, Zhang S, Marzolf B, Troisch P, Brightman A et al. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106: 4402-4407. PubMed: 19246379.
[13]
Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301. PubMed: 20146939.
[14]
Zhu HT, Dong QZ, Wang G, Zhou HJ, Ren N et al. (2012) Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol 50: 49-56. doi:10.1007/s12033-011-9414-6. PubMed: 21567136.
[15]
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034. PubMed: 12184808.
[16]
Andersen CL, Jensen JL, ？rntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250. doi:10.1158/0008-5472.CAN-04-0496. PubMed: 15289330.
[17]
Suzuki T, Higgins PJ, Crawford DR (2000) Control selection for RNA quantitation. BioTechniques 29: 332-337. PubMed: 10948434.
[18]
Choong ML, Yang HH, McNiece I (2007) MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol 35: 551-564. PubMed: 17379065.
[19]
Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY (2007) MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67: 8433-8438. PubMed: 17823410.
[20]
Wang XH, Tang S, Le SY, Lu R, Rader JS et al. (2008) Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth. PLOS ONE 3: e2557. PubMed: 18596939.
[21]
Yousef GM, Youssef YM, White NMA, Grigull J, Krizova A et al. (2011) Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature. Eur Urol 59: 721-730. PubMed: 21272993.
[22]
Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE et al. (2009) MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy. PLOS ONE 4: e5889. PubMed: 19521514.
[23]
Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C et al. (2009) MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A 106: 5330-5335. PubMed: 19289845.
[24]
Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL et al. (2009) miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice. PLOS ONE 4: e7542. PubMed: 19855844.
[25]
Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D et al. (2011) Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 56: 595-601. PubMed: 21753766.
[26]
Zhi F, Chen X, Wang S, Xia X, Shi Y et al. (2010) The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46: 1640-1649. PubMed: 20219352.
[27]
Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852. PubMed: 18375788.
[28]
Shen Y, Li Y, Ye F, Wang F, Wan X et al. (2011) Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Exp Mol Med 43: 358-366. PubMed: 21519184.
[29]
Ng EK, Chong WW, Jin H, Lam EK, Shin VY et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381. doi:10.1136/gut.2008.167817. PubMed: 19201770.
[30]
Ai J, Zhang R, Li Y, Pu J, Lu Y et al. (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 391: 73-77. PubMed: 19896465.
[31]
Huang Z, Huang D, Ni S, Peng Z, Sheng W et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126. doi:10.1002/ijc.25007. PubMed: 19876917.
[32]
Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW et al. (2010) Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 16: 360-364. doi:10.1111/j.1601-0825.2009.01646.x. PubMed: 20233326.
[33]
Wang J, Chen J, Chang P, LeBlanc A, Li D et al. (2009) MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer. Prev Res (Phila) 2: 807-813. doi:10.1158/1940-6207.CAPR-09-0094.
Chen X, Hu Z, Wang W, Ba Y, Ma L et al. (2012) Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 130: 1620-1628. PubMed: 21557218.
[36]
Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM et al. (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112: 55-59. PubMed: 18954897.
[37]
Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY et al. (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70: 9798-9807. PubMed: 21098710.
[38]
Suzuki T, Higgins PJ, Crawford DR (2000) Control selection for RNA quantitation. BioTechniques 29: 332-337. PubMed: 10948434.
[39]
McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840. doi:10.1373/clinchem.2010.157198. PubMed: 21487102.
[40]
Zhang Y, Liu D, Chen X, Li J, Li L et al. (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39: 133-144. doi:10.1016/j.molcel.2010.06.010. PubMed: 20603081.
[41]
Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008. PubMed: 21383194.
[42]
Song J, Bai Z, Han W, Zhang J, Meng H et al. (2012) Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 57: 897-904. PubMed: 22198701.
